News

GSK embraces gummy delivery format

BY Michael Johnsen

CLIFTON, N.J. — GlaxoSmithKline launched Tums Chewy Delights, bringing to the iconic antacid brand a gummy delivery format. Tums Chewy Delights offers Tums Ultra strength heartburn relief in two new flavors: very cherry and smooth peppermint. One of the last new-format introductions from GlaxoSmithKline — Tums Smoothies — shared growth of 3.9% to $36.3 million in sales for the 52 weeks ended Aug. 10 across total U.S. multi-outlets, according to IRI.

(Click here to view the full category review.)

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

P&G adds to Metamucil brand with MetaBiotic

BY Michael Johnsen

NEW YORK — Procter & Gamble earlier this year added some heft to its Metamucil brand with a pair of line extensions that create a linear brand block. P&G launched MetaBiotic, a 2-in-1 probiotic supplement containing Bio-Active 12, which maintains digestive balance and promotes a healthy immune system, and Meta Health Bars, fiber bars containing psyllium fiber.

(Click here to view the full category review.)

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Switch, relaunch increase sales

BY Michael Johnsen

The big story in the digestives space is the switch and launch in May of Pfizer’s Nexium 24HR. In a little more than 10 weeks on the shelf, the brand has generated $53.6 million in sales across total U.S. multi-outlets for the 52 weeks ended Aug. 10, according to IRI. At that pace, annual sales of Nexium 24HR will approach — if not exceed — $300 million, which will make it the No. 2 brand behind Procter & Gamble’s Prilosec OTC.

(Click here to view the full category review.)

Nexium 24HR is the fourth proton-pump inhibitor to cross over from prescription-only to nonprescription, and while it’s becoming a crowded space, Nexium 24HR generated $2.1 billion in prescription sales in 2013, according to prescription patent holder AstraZeneca. So there now are a significant number of new patients shopping OTC digestive aisles.

Chattem’s Rolaids have been on the shelf for a little more than a year now, generating $21.2 million in sales and ranking the brand at No. 14 among antacid tablets. And Bayer’s Alka Seltzer Fruit Chews has helped lift sales of the Alka Seltzer brand $15.9 million on 230.2% year-over-year growth.

Probiotics also have trended well, with the best-selling probiotic, P&G’s Align, generating $72.3 million on a sales incline of 4.9%. I-Health’s Culturelle and Bayer’s Trubiotic are on sharper growth trajectories with $74.1 million in sales on growth of 20.1% and sales of $24.3 million, up 51.7%, respectively.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?